Beauty Health officer reports tax share withholding

Beauty Health Co executive Sheri Lewis reported a routine tax-related share disposition.

Rhea-AI Filing Summary

Beauty Health Co executive Sheri Lewis reported a routine tax-related share disposition. On March 17, she had 51,883 shares of Class A common stock withheld by the company at $1.17 per share to cover tax obligations on vesting restricted stock units. The footnote clarifies this was not an open-market sale, and she still directly holds 862,843 shares after the transaction.

Insider Trade Summary

Exercise Price or Tax Liability: 51,883 shares

Exercise Price or Tax Liability 1 txn

Insider Lewis Sheri

Role CSO and COO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	51,883	$1.17	$61K

Holdings After Transaction: Class A Common Stock — 862,843 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sheri Lewis report in this SKIN Form 4 filing?

Sheri Lewis reported a tax-related share disposition. The company withheld 51,883 shares of Class A common stock at $1.17 per share to satisfy tax withholding on vesting restricted stock units, rather than executing an open-market sale of shares.

Was the Sheri Lewis SKIN Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The filing states the 51,883 shares were withheld by the issuer solely to satisfy tax withholding requirements on vesting restricted stock units, and explicitly notes that this withholding does not represent a sale.

How many Beauty Health (SKIN) shares were involved in Sheri Lewis’s tax withholding?

The tax withholding involved 51,883 shares of Class A common stock. These shares were retained by the issuer at a price of $1.17 per share to cover tax obligations triggered by the vesting of restricted stock units granted to Sheri Lewis.

How many SKIN shares does Sheri Lewis hold after this Form 4 transaction?

After the tax-withholding transaction, Sheri Lewis directly holds 862,843 shares of Beauty Health’s Class A common stock. The filing shows this balance as her total direct ownership following the issuer’s withholding of 51,883 shares for restricted stock unit tax obligations.

What is the purpose of the share withholding reported by Sheri Lewis for SKIN?

The share withholding was used to pay taxes on vesting restricted stock units. Instead of paying cash, 51,883 shares of Class A common stock were withheld by Beauty Health, satisfying tax liabilities associated with equity compensation while avoiding an open-market share sale.

What role does Sheri Lewis hold at Beauty Health (SKIN) in this Form 4?

In this Form 4, Sheri Lewis is identified as an officer of Beauty Health, serving as CSO and COO. The reported transaction reflects equity compensation mechanics and related tax withholding tied to her role, rather than discretionary buying or selling of company stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Sheri

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CSO and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/17/2026		F(1)		51,883	D	$1.17	862,843	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Sheri Lewis	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)